Dipna Pharmachem Limited has announced a board meeting approving key leadership changes.

Mr. Keyur Shah joins as Chief Financial Officer, bringing over six years of experience in pharma trading and finance.

Mr. Parin Bhavsar is appointed as an Additional Non-Executive Independent Director, with expertise in corporate law, GST, and startup advisory.

Ms. Dipna Shah is named Chairperson; she has over a decade of experience in pharma and chemical trading and finance.

Additionally, the Nomination and Remuneration, Stakeholders Relationship, and Audit Committees have been reconstituted with these directors in key roles, aiming to strengthen governance.